Harvard Scientist Claims Selenium Can Treat Ebola
In an article just published in the British Journal of Medicine and Medical Research Harvard University researcher Dr Boguslaw Lipinski claims that selenium can treat Ebola virus disease (EVD). His paper says that a specific form of selenium, sodium selenite, found in nutritional supplements can reduce the infectivity and therefore the reproduction of Ebola and HIV viruses.
The article entitled, “Can Selenite be an Ultimate Inhibitor of Ebola and Other Viral Infections?” explains that sodium selenite (selenium) can reduce or prevent viruses from entering cells to infect them. He writes, “This inexpensive and readily available food supplement can be an ultimate inhibitor of Ebola and other enveloped viral infections.” However, he suggests selenium should not be used with vitamin C which can inactivate it.
He explains, “Selenium deficiencies are associated with enhanced infectivity of Ebola and other viruses.” In fact, “those who are resistant to Ebola infections may have adequate blood concentrations of selenite.”
Selenium tablets containing sodium selenite are available at many pharmacies in Liberia.
This article helps explain why in August when patients at ELWA-2 Ebola treatment unit were given only six selenium tablets a day their average survival rate increased from 44% to 68%. According to selenium expert Howard Armistead, if they had been given the full dose of ten tablets daily, 75% of the patients should have survived.
Dr Lapinski explained that selenium is, “particularly important for the protection of large populations against the threat of Ebola epidemics.” He says that he hopes his article “will stimulate research efforts aimed at preventing the emerging threat of Ebola virus epidemics by the use of sodium selenite.”
Reference: Lipinski;BJMMR,6(3):319-324 Article no.BJMMR.2015.207
Comments
Post a Comment